Is MEN1 p.Pro514Ser (c.1540C>T) pathogenic?

MEN1 p.Pro514Ser (c.1540C>T) is classified Conflicting classifications of pathogenicity in MEN1 (ClinVar, Conflicting submitters, 3 submitters; last evaluated 2025-09-23). AlphaMissense: likely benign (0.0593); Very rare (popmax 0.00267%, afr); Associated with hereditary neoplastic syndrome.

What condition is associated with MEN1 p.Pro514Ser (c.1540C>T)?

MEN1 p.Pro514Ser (c.1540C>T) is associated with hereditary neoplastic syndrome, multiple endocrine neoplasia type 1 (ClinVar).

How common is MEN1 p.Pro514Ser (c.1540C>T) in the general population?

MEN1 p.Pro514Ser (c.1540C>T) is very rare (popmax 0.00267%, afr) (gnomAD).

What do computational predictors say about MEN1 p.Pro514Ser (c.1540C>T)?

AlphaMissense predicts likely benign (score 0.0593) — an in-silico prediction, not a clinical call.

MEN1 p.Pro514Ser

c.1540C>T · rs150202288 · VCV567574

Conflicting classifications of pathogenicity Conflicting submitters

Classification

Conflicting classifications of pathogenicity

ClinVar

Review

Conflicting submitters ★☆☆☆

ClinVar · 3 submitters

AlphaMissense

likely benign

0.0593 · ACMG-weighted

gnomAD v4.1

Rare

very rare (popmax 0.00267%, afr)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
AlphaMissense	0.0593	likely benign
REVEL	0.306	indeterminate
SaProt	—	withheld · numbering disagrees past residue 150 · why
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP 3	GERP 0.26, phastCons 1
Regional constraint	o/e 0.96	unconstrained · MANE · 180 bp · p 0.7 · regional, not allelic
Overall
CADD	16.44	PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

⚠ Isoform check: AlphaMissense numbered on a different transcript (AM P519S vs ClinVar P514S) — verify the residue.

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.00267% African / African-American · 2/74,964 alleles

Filtering AF 0.000443% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000166%

Overall 0.000436% 7/1,606,700 alleles · very rare exomes 4/1,454,380 · genomes 3/152,320 · joint denominator

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.00267%	37,482
East Asian	0.00223%	44,798
South Asian	0.0011%	90,908
European (non-Finnish)	0.000255%	392,707

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: MEN1
Protein: p.Pro514Ser
Coding: c.1540C>T
MANE Select: NM_001370259
dbSNP: rs150202288
Type: single nucleotide variant
Location: chr11:64804627 (GRCh38)
Gene constraint: LOEUF 0.206 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 85.13 · 69 PDB

Full MEN1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: multiple endocrine neoplasia type 1

Similar variants

MEN1 p.Pro514His Uncertain significance ★★ ⚠ same residue
MEN1 p.Pro514Leu Uncertain significance ★★ same residue
MEN1 p.Pro514= Likely benign ★★ same residue
MEN1 p.Pro514Arg Conflicting classifications of pathogenicity ★ ⚠ same residue
MEN1 p.Pro514Thr Conflicting classifications of pathogenicity ★ same residue
MEN1 c.1049+1G>A Pathogenic ★★ same condition
MEN1 c.1049+1G>C Pathogenic ★★ same condition
MEN1 c.1049+2T>C Pathogenic/Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/men1-p-pro514ser (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown